LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Alkermes (NASDAQ: ALKS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Sell
$19.34
12,090
$234K
188,323
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Sell
$24.59
12,044
$296K
130,300
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Sell
$20.03
12,452
$249K
116,722
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Sell
$26.82
12,411
$333K
110,616
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Buy
$26.82
12,411
$333K
108,727
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Buy
$24.59
12,044
$296K
96,316
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Buy
$19.34
12,090
$234K
84,272
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Buy
$20.03
12,452
$249K
72,182
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/09/2024
Sell
$32.07
61,151
$1.961M
47,576
NASDAQ ALKS Alkermes
LAURENCIN CATO T / director
12/09/2024
Buy
$22.52
2,691
$61K
25,704
NASDAQ ALKS Alkermes
LAURENCIN CATO T / director
12/09/2024
Sell
$31.85
2,691
$86K
23,013
NASDAQ ALKS Alkermes
LAURENCIN CATO T / director
12/08/2024
Sell
$31.46
958
$30K
23,013
NASDAQ ALKS Alkermes
LAURENCIN CATO T / director
12/09/2024
Sell
$22.52
2,691
$61K
16,142
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/05/2024
Sell
$31.50
9,221
$290K
59,730
NASDAQ ALKS Alkermes
Hopkinson Craig C. / officer: EVP R&D, Chief Medical Officer
12/04/2024
Sell
$30.77
14,349
$442K
68,951
NASDAQ ALKS Alkermes
Nichols Christian Todd / officer: SVP, Chief Commercial Officer
11/27/2024
Sell
$29.15
5,208
$152K
60,703